Physician

Matthew Alexander Cunningham, MD

According to 2025 Medicare claims, Matthew Cunningham, MD (NPI: 1336303247) practices ophthalmology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 32159-4540.

Cunningham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,653 traditional Medicare patients, billed 41,859 HCPCS/CPT codes, and received $4,027,314 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,544 prescription claims across 442 beneficiaries totaling $373,838 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 375 records totaling $1,037,433. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $816,200 to $4,027,314. Similarly, Part D prescription costs have risen steadily, from $44,170 to $373,838. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.1M2015 Medicare payment: $816,200 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,160,149 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,275,865 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,084,522 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,471,913 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,968,875 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,815,474 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,691,738 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,077,080 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,027,314 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,31611,650$816,200
20161,43115,026$1,160,149
20171,58517,913$1,275,865
20181,77919,557$2,084,522
20191,83821,418$3,471,913
20201,82220,846$3,968,875
20211,69119,819$3,815,474
20221,70220,524$3,691,738
20231,81936,226$4,077,080
20241,65341,859$4,027,314

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$193K$387K2015 Drug cost: $44,170 (USD; Tot_Drug_Cst)2016 Drug cost: $105,804 (USD; Tot_Drug_Cst)2017 Drug cost: $123,336 (USD; Tot_Drug_Cst)2018 Drug cost: $195,500 (USD; Tot_Drug_Cst)2019 Drug cost: $219,121 (USD; Tot_Drug_Cst)2020 Drug cost: $338,053 (USD; Tot_Drug_Cst)2021 Drug cost: $306,380 (USD; Tot_Drug_Cst)2022 Drug cost: $316,518 (USD; Tot_Drug_Cst)2023 Drug cost: $386,821 (USD; Tot_Drug_Cst)2024 Drug cost: $373,838 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015225569$44,170
2016303819$105,804
20173451,018$123,336
20183351,130$195,500
20193471,220$219,121
20203901,532$338,053
20214071,554$306,380
20224201,411$316,518
20234881,579$386,821
20244421,544$373,838

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5382,146$92
92014Established patient complete exam of visual system790854$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more574736$65
92134Imaging of retina6961,660$30
92250Photography of the retina1,3901,579$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept1062,968$231,256
SyfovrePegcetacoplan/Pf23590$50,370
LucentisRanibizumab12336$23,400
Prednisolone AcetatePrednisolone Acetate33115,514$13,426
CombiganBrimonidine Tartrate/Timolol21918$8,732

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.93$100,814Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.282$936,619Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Alexander Cunningham, MD?

Tedicare shows public-source Medicare data for Matthew Alexander Cunningham, MD (NPI 1336303247), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Alexander Cunningham, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Alexander Cunningham, MD?

Matthew Alexander Cunningham, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Matthew Alexander Cunningham, MD have Open Payments data?

Matthew Alexander Cunningham, MD has 375 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.